Bharat Immunolog Stock Price Today (NSE: 524663)
Fundamental Score
Bharat Immunolog Share Price Live NSE/BSE & Institutional Fundamental Analysis
Bharat Immunolog share price today is ₹20.13, up +0.00% on NSE/BSE as of 30 September 2025. Bharat Immunolog (524663) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹86.92 (Cr). The 52-week high for 524663 share price is ₹N/A and the 52-week low is ₹N/A. The company has a Return on Equity (ROE) of -17.67% and a debt-to-equity ratio of 0.94.
Bharat Immunolog Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Bharat Immunolog Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Research report currently being updated.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Bharat Immunolog Fundamental Analysis & Valuation Benchmarking
Educational evaluation of 524663 across key market metrics for learning purposes.
Positive Indicators
2 factors identified
Balanced Promoter Holding (59.25%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-17.67%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-9.27%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-17.84%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-59.74%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-100.00%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Interest Coverage (-2.26x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-17.50 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Bharat Immunolog Financial Statements
Comprehensive financial data for Bharat Immunolog including income statement, balance sheet and cash flow
About 524663 (Bharat Immunolog)
Bharat Immunolog (524663) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Pharmaceuticals sector with a current market capitalisation of ₹86.92 (Cr). Bharat Immunolog has delivered a Return on Equity (ROE) of -17.67% and a ROCE of -9.27%. The debt-to-equity ratio stands at 0.94, reflecting the company's capital structure. Investors tracking 524663 share price can monitor key metrics including P/E ratio, promoter holding of 59.25%, and quarterly earnings growth.
Company Details
524663 Share Price: Frequently Asked Questions
What is the current share price of Bharat Immunolog (524663)?
As of 30 Sept 2025, 03:25 pm IST, Bharat Immunolog share price is ₹20.13. The 524663 stock has a market capitalisation of ₹86.92 (Cr) on NSE/BSE.
Is 524663 share price Overvalued or Undervalued?
524663 share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 31.77x. Based on this relative valuation, the Bharat Immunolog stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of 524663 share price?
The 52-week high of 524663 share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Bharat Immunolog share price?
Key factors influencing 524663 share price include quarterly earnings growth (Sales Growth: -100.00%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Bharat Immunolog a good stock for long-term investment?
Bharat Immunolog shows a 5-year Profit Growth of N/A% and an ROE of -17.67%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.94 before investing in 524663 shares.
How does Bharat Immunolog compare with its industry peers?
Bharat Immunolog competes with major peers in the Pharmaceuticals. Investors should compare 524663 share price P/E of 0.00x and ROE of -17.67% against the industry averages to determine competitive standing.
What is the P/E ratio of 524663 and what does it mean?
524663 share price has a P/E ratio of N/Ax compared to the industry average of 31.77x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is 524663 performing according to Bull Run's analysis?
524663 has a Bull Run fundamental score of 7/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does 524663 belong to?
524663 operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting Bharat Immunolog share price.
What is Return on Equity (ROE) and why is it important for 524663?
524663 has an ROE of -17.67%, which suggests challenges in generating returns from shareholders equity. ROE measures how efficiently Bharat Immunolog generates profits from shareholders capital.
How is 524663 debt-to-equity ratio and what does it indicate?
524663 has a debt-to-equity ratio of 0.94, which indicates moderate leverage that should be monitored.
What is 524663 dividend yield and is it a good dividend stock?
524663 offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Bharat Immunolog shares.
How has 524663 share price grown over the past 5 years?
524663 has achieved 5-year growth rates of: Sales Growth 5.09%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in 524663 and why does it matter?
Promoters hold 59.25% of 524663 shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Bharat Immunolog.
What is 524663 market capitalisation category?
524663 has a market capitalisation of ₹87 crores, placing it in the Small-cap category.
How volatile is 524663 stock?
524663 has a beta of N/A. A beta > 1 suggests the Bharat Immunolog stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is 524663 operating profit margin trend?
524663 has a 5-year average Operating Profit Margin (OPM) of -17.84%, indicating the company's operational efficiency.
How is 524663 quarterly performance?
Recent quarterly performance shows Bharat Immunolog YoY Sales Growth of -100.00% and YoY Profit Growth of -59.74%.
What is the institutional holding pattern in 524663?
524663 has FII holding of N/A% and DII holding of N/A%. Significant institutional holding often suggests professional confidence in the Bharat Immunolog stock.